APO RESEARCH · REPORT
Mesenchymal Stem Cells
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
Product & engineering
Understand the product.
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
Selected research
Industry Research
Mesenchymal Stem Cells Industry Research Report 2026
Market perspective
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
The top 3 manufacturters of Mesenchymal Stem Cells include Lonza, Thermo Fisher and Bio-Techne, with about 56% market shares.
North America region is the largest consumption of Mesenchymal Stem Cells, with a sales revenue market share nearly 41%. Europe is the second largest consumer of Mesenchymal Stem Cells, enjoying sales revenue market share about 31%.
Read the full market overview
Report Scope
This report quantifies the global Mesenchymal Stem Cells market in terms of revenue (US$ million) and, where applicable, service volume (Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Mesenchymal Stem Cells.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Mesenchymal Stem Cells Market by Company
Lonza
Thermo Fisher
Bio-Techne
ATCC
MilliporeSigma
PromoCell GmbH
Genlantis
Celprogen
Cell Applications
Cyagen Biosciences
Axol Bioscience
Mesenchymal Stem Cells Segment by Type
Human MSC
Mouse MSC
Rat MSC
Others
Mesenchymal Stem Cells Segment by Application
Research Institute
Hospital
Others
Mesenchymal Stem Cells Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesenchymal Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mesenchymal Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesenchymal Stem Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Mesenchymal Stem Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Human MSC
- Mouse MSC
- Rat MSC
- Others
Applications
- Research Institute
- Hospital
- Others
Companies covered
- Lonza
- Thermo Fisher
- Bio-Techne
- ATCC
- MilliporeSigma
- PromoCell GmbH
- Genlantis
- Celprogen
- Cell Applications
- Cyagen Biosciences
- Axol Bioscience
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Mesenchymal Stem Cells by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Human MSC
- 2.2.3 Mouse MSC
- 2.2.4 Rat MSC
- 2.2.5 Others
- 2.3 Mesenchymal Stem Cells by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Research Institute
- 2.3.3 Hospital
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Mesenchymal Stem Cells Breakdown Data by Type
- 3.1 Global Mesenchymal Stem Cells Historic Market Size by Type (2021-2026)
- 3.2 Global Mesenchymal Stem Cells Forecasted Market Size by Type (2027-2032)
4 Mesenchymal Stem Cells Breakdown Data by Application
- 4.1 Global Mesenchymal Stem Cells Historic Market Size by Application (2021-2026)
- 4.2 Global Mesenchymal Stem Cells Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Mesenchymal Stem Cells Market Perspective (2021-2032)
- 5.2 Global Mesenchymal Stem Cells Growth Trends by Region
- 5.2.1 Global Mesenchymal Stem Cells Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Mesenchymal Stem Cells Historic Market Size by Region (2021-2026)
- 5.2.3 Mesenchymal Stem Cells Forecasted Market Size by Region (2027-2032)
- 5.3 Mesenchymal Stem Cells Market Dynamics
- 5.3.1 Mesenchymal Stem Cells Industry Trends
- 5.3.2 Mesenchymal Stem Cells Market Drivers
- 5.3.3 Mesenchymal Stem Cells Market Challenges
- 5.3.4 Mesenchymal Stem Cells Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Mesenchymal Stem Cells Players by Revenue
- 6.1.1 Global Top Mesenchymal Stem Cells Players by Revenue (2021-2026)
- 6.1.2 Global Mesenchymal Stem Cells Revenue Market Share by Players (2021-2026)
- 6.2 Global Mesenchymal Stem Cells Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Mesenchymal Stem Cells Head Office and Area Served
- 6.4 Global Mesenchymal Stem Cells Players, Product Type & Application
- 6.5 Global Mesenchymal Stem Cells Manufacturers Established Date
- 6.6 Global Mesenchymal Stem Cells Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Mesenchymal Stem Cells Market Size (2021-2032)
- 7.2 North America Mesenchymal Stem Cells Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Mesenchymal Stem Cells Market Size by Country (2021-2026)
- 7.4 North America Mesenchymal Stem Cells Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Mesenchymal Stem Cells Market Size (2021-2032)
- 8.2 Europe Mesenchymal Stem Cells Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Mesenchymal Stem Cells Market Size by Country (2021-2026)
- 8.4 Europe Mesenchymal Stem Cells Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Mesenchymal Stem Cells Market Size (2021-2032)
- 9.2 Asia-Pacific Mesenchymal Stem Cells Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Mesenchymal Stem Cells Market Size (2021-2032)
- 10.2 South America Mesenchymal Stem Cells Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Mesenchymal Stem Cells Market Size by Country (2021-2026)
- 10.4 South America Mesenchymal Stem Cells Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Mesenchymal Stem Cells Market Size (2021-2032)
- 11.2 Middle East & Africa Mesenchymal Stem Cells Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Lonza
- 12.1.1 Lonza Company Information
- 12.1.2 Lonza Business Overview
- 12.1.3 Lonza Revenue in Mesenchymal Stem Cells Business (2021-2026)
- 12.1.4 Lonza Mesenchymal Stem Cells Product Portfolio
- 12.1.5 Lonza Recent Developments
- 12.2 Thermo Fisher
- 12.2.1 Thermo Fisher Company Information
- 12.2.2 Thermo Fisher Business Overview
- 12.2.3 Thermo Fisher Revenue in Mesenchymal Stem Cells Business (2021-2026)
- 12.2.4 Thermo Fisher Mesenchymal Stem Cells Product Portfolio
- 12.2.5 Thermo Fisher Recent Developments
- 12.3 Bio-Techne
- 12.3.1 Bio-Techne Company Information
- 12.3.2 Bio-Techne Business Overview
- 12.3.3 Bio-Techne Revenue in Mesenchymal Stem Cells Business (2021-2026)
- 12.3.4 Bio-Techne Mesenchymal Stem Cells Product Portfolio
- 12.3.5 Bio-Techne Recent Developments
- 12.4 ATCC
- 12.4.1 ATCC Company Information
- 12.4.2 ATCC Business Overview
- 12.4.3 ATCC Revenue in Mesenchymal Stem Cells Business (2021-2026)
- 12.4.4 ATCC Mesenchymal Stem Cells Product Portfolio
- 12.4.5 ATCC Recent Developments
- 12.5 MilliporeSigma
- 12.5.1 MilliporeSigma Company Information
- 12.5.2 MilliporeSigma Business Overview
- 12.5.3 MilliporeSigma Revenue in Mesenchymal Stem Cells Business (2021-2026)
- 12.5.4 MilliporeSigma Mesenchymal Stem Cells Product Portfolio
- 12.5.5 MilliporeSigma Recent Developments
- 12.6 PromoCell GmbH
- 12.6.1 PromoCell GmbH Company Information
- 12.6.2 PromoCell GmbH Business Overview
- 12.6.3 PromoCell GmbH Revenue in Mesenchymal Stem Cells Business (2021-2026)
- 12.6.4 PromoCell GmbH Mesenchymal Stem Cells Product Portfolio
- 12.6.5 PromoCell GmbH Recent Developments
- 12.7 Genlantis
- 12.7.1 Genlantis Company Information
- 12.7.2 Genlantis Business Overview
- 12.7.3 Genlantis Revenue in Mesenchymal Stem Cells Business (2021-2026)
- 12.7.4 Genlantis Mesenchymal Stem Cells Product Portfolio
- 12.7.5 Genlantis Recent Developments
- 12.8 Celprogen
- 12.8.1 Celprogen Company Information
- 12.8.2 Celprogen Business Overview
- 12.8.3 Celprogen Revenue in Mesenchymal Stem Cells Business (2021-2026)
- 12.8.4 Celprogen Mesenchymal Stem Cells Product Portfolio
- 12.8.5 Celprogen Recent Developments
- 12.9 Cell Applications
- 12.9.1 Cell Applications Company Information
- 12.9.2 Cell Applications Business Overview
- 12.9.3 Cell Applications Revenue in Mesenchymal Stem Cells Business (2021-2026)
- 12.9.4 Cell Applications Mesenchymal Stem Cells Product Portfolio
- 12.9.5 Cell Applications Recent Developments
- 12.10 Cyagen Biosciences
- 12.10.1 Cyagen Biosciences Company Information
- 12.10.2 Cyagen Biosciences Business Overview
- 12.10.3 Cyagen Biosciences Revenue in Mesenchymal Stem Cells Business (2021-2026)
- 12.10.4 Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio
- 12.10.5 Cyagen Biosciences Recent Developments
- 12.11 Axol Bioscience
- 12.11.1 Axol Bioscience Company Information
- 12.11.2 Axol Bioscience Business Overview
- 12.11.3 Axol Bioscience Revenue in Mesenchymal Stem Cells Business (2021-2026)
- 12.11.4 Axol Bioscience Mesenchymal Stem Cells Product Portfolio
- 12.11.5 Axol Bioscience Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst